# OnCo record histrelin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/histrelin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "histrelin" ;
  schema:name "Histrelin"@en ;
  schema:alternateName "Histrelin acetate"@en, "Vantas / Supprelin LA" ;
  schema:description "Histrelin is a GnRH agonist delivered by a small implant under the skin of the arm that lasts a whole year, approved in the United States as Vantas for palliative treatment of advanced prostate cancer and as Supprelin for early puberty in children."@en ;
  schema:url <https://onco.cc/drugs/histrelin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Histrelin> ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022058>, <https://en.wikipedia.org/wiki/Histrelin>, <https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL1201303> ;
  onco:status "established" ;
  onco:tag "gap-fill", "chembl-universe" ;
  onco:modality "GnRH agonist, twelve-month subcutaneous implant" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/gnrhr/> ;
  onco:drugs <https://onco.cc/drugs/leuprolide/>, <https://onco.cc/drugs/goserelin/> ;
  onco:companies <https://onco.cc/companies/endo/> ;
  onco:trials <https://onco.cc/trials/nct01697384/>, <https://onco.cc/trials/nct01394263/>, <https://onco.cc/trials/nct04513717/> .